Fallopian Tube Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
Condition: Olaparib Manintenance Therapy in BRCA 1/BRCA2 Wilde Type Ovarian Cancer Patients Intervention: Drug: Olaparib Oral Product Sponsor: National Cancer Institute, Naples Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2022 Category: Research Source Type: clinical trials
